Narcosine

那可丁

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameNarcosine
Drug Alias NameNoscapine诺斯卡品诺司卡品NoscapinaNoscapinum +[13] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTubulin inhibitorsMitosis inhibitorsApoptosis stimulants
TargetsNot applicable
Therapy Area/IndicationsCoughMultiple MyelomaLymphoma, Non-Hodgkin +[4] 
Global Approved IndicationsCough
Approved Indications in ChinaCough
Original Approved Country/TerritoryMainland China
Original Approved Date1996/01/01
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesQinghai Pharmaceutical Co LtdNortheast Pharmaceutical Group Shenyang No 1 Pharmaceutical Co Ltd
Inactive CompaniesCougar Biotechnology IncUniversity Of Southern California
Active IndicationsCough
Inactive IndicationsMultiple MyelomaLymphoma, Non-HodgkinLeukemia, Lymphocytic, Chronic, B-Cell

Other Information

ATC CodeR05DA07
Related LinksWikipedia